Poseida Therapeutics, Inc.股价拉升224.57% 市值涨20.32亿美元_老虎社区_美港股上老虎

Poseida Therapeutics, Inc.股价拉升224.57% 市值涨20.32亿美元

市场透视11-26 22:31

北京时间2024年11月26日22时31分，Poseida Therapeutics, Inc.（PSTX.us）股票出现波动，股价急速上涨224.57%。截至发稿，该股报9.28美元/股，成交量960.495万股，换手率9.85%，振幅1.75%。最近的财报数据显示，该股实现营业收入71.75百万美元，净利润20.24百万美元，每股收益0.21美元，毛利70.45百万美元，市盈率-14.73倍。...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

暂无评论

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2486700196?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-11-26 22:31","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2486700196","market":"us","top_or_hot":-1,"title":"Poseida Therapeutics, Inc.股价拉升224.57% 市值涨20.32亿美元","media":"市场透视","content":"<div>\n<p>北京时间2024年11月26日22时31分，Poseida Therapeutics, Inc.（PSTX.us）股票出现波动，股价急速上涨224.57%。截至发稿，该股报9.28美元/股，成交量960.495万股，换手率9.85%，振幅1.75%。最近的财报数据显示，该股实现营业收入71.75百万美元，净利润20.24百万美元，每股收益0.21美元，毛利70.45百万美元，市盈率-14.73倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126223201abe0bc96&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Poseida Therapeutics, Inc.股价拉升224.57% 市值涨20.32亿美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPoseida Therapeutics, Inc.股价拉升224.57% 市值涨20.32亿美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-26 22:31 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126223201abe0bc96&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年11月26日22时31分，Poseida Therapeutics, Inc.（PSTX.us）股票出现波动，股价急速上涨224.57%。截至发稿，该股报9.28美元/股，成交量960.495万股，换手率9.85%，振幅1.75%。最近的财报数据显示，该股实现营业收入71.75百万美元，净利润20.24百万美元，每股收益0.21美元，毛利70.45百万美元，市盈率-14.73倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126223201abe0bc96&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PSTX","symbol_name":"Poseida Therapeutics, Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126223201abe0bc96&s=b","article_id":"2486700196","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126223201abe0bc96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2486700196","pubTimestamp":1732631518,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年11月26日22时31分，Poseida Therapeutics, Inc.股票出现波动，股价急速上涨224.57%。Poseida Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。消息层面，截至22时31分，《罗氏15亿美元收购Poseida 预计明年一季度完成交易》资讯为影响Poseida Therapeutics, Inc.的重要信息。该信息摘要如下：临床阶段同种异体细胞治疗和基因药物领域的领先企业Poseida Therapeutics宣布将被罗氏控股以约15亿美元的总股权价值收购。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"PSTX":"Poseida Therapeutics, Inc.","LENZ":"Therapeutics","BK4139":"生物科技"},"translate_title":"Poseida Therapeutics, Inc. Stock Rises 224.57%, Market Value Rises $2.032 Billion","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1,"PSTX":1},"content_text":"北京时间2024年11月26日22时31分，Poseida Therapeutics, Inc.（PSTX.us）股票出现波动，股价急速上涨224.57%。截至发稿，该股报9.28美元/股，成交量960.495万股，换手率9.85%，振幅1.75%。最近的财报数据显示，该股实现营业收入71.75百万美元，净利润20.24百万美元，每股收益0.21美元，毛利70.45百万美元，市盈率-14.73倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Poseida Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。其相关个股中，Poseida Therapeutics, Inc.、Arrowhead Pharmaceuticals, Inc.、Fate Therapeutics, Inc.涨幅较大，Oncternal Therapeutics, Inc.、Citius Pharmaceuticals, Inc.、Poseida Therapeutics, Inc.较为活跃，换手率分别为13.27%、10.47%、9.86%，振幅较大的相关个股有Citius Pharmaceuticals, Inc.、Caribou Biosciences, Inc.、Fate Therapeutics, Inc.，振幅分别为19.17%、13.61%、11.78%。Poseida Therapeutics, Inc.公司简介：Poseida Therapeutics Inc是一家临床阶段的生物制药公司，致力于利用非病毒基因工程技术为患有高度未满足医疗需求的患者创造拯救生命的疗法。 它已建立了自体和同种异体嵌合抗原受体T细胞或CAR-T候选产品线，最初专注于治疗血液恶性肿瘤和实体瘤。消息层面，截至22时31分，《罗氏15亿美元收购Poseida 预计明年一季度完成交易》资讯为影响Poseida Therapeutics, Inc.的重要信息。该信息摘要如下：临床阶段同种异体细胞治疗和基因药物领域的领先企业Poseida Therapeutics(PSTX.US)宣布将被罗氏控股以约15亿美元的总股权价值收购。预计整个交易将于2025年第一季度顺利完成。自2022年起，Poseida与罗氏已携手合作开发针对血液系统恶性肿瘤患者的即用型CAR-T细胞疗法。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}